Role of olmesartan in ameliorating diabetic nephropathy in rats by targeting the AGE/PKC, TLR4/P38-MAPK and SIRT-1 autophagic signaling pathways
Nesma M.E. Abo El- Nasr, Dalia O. Saleh, Ingy M. Hashad
Topics & Concepts
Diabetic nephropathyOlmesartanStreptozotocinEndocrinologyInternal medicineMedicineDiabetes mellitusPioglitazoneNephropathyPharmacologyType 2 diabetesBlood pressureAdvanced Glycation End Products researchApelin-related biomedical researchChronic Kidney Disease and Diabetes